🔎 Trials Near Me

Hem › Major depression › Arizona

Kliniska studier för Major depression i Arizona

13 studier för Major depression söker deltagare vid platser i Arizona.

Städer i Arizona

Officiell studietext (engelska)

A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

  • NoesisPharma, LLC, Phoenix
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07775300

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

  • University of Arizona, Tucson
RekryterarFas 3
Ålder 18 till 74 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06559306

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

  • IMA Clinical Research- Phoenix, Phoenix
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07621237

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

  • Lighthouse Psychiatry, Gilbert
RekryterarFas 3
Ålder 18 till 85 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06793397

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

  • Vanda Investigational Site, Phoenix
RekryterarFas 3
Ålder 18 till 65 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06830044

Lumateperone for Late-Life Depression

  • University of Arizona, Tucson
RekryterarFas 3
Ålder 60 och äldre · Alla kön · Uppdaterad 16 sep. 2026 · NCT07623135

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

  • Draig Clinical Site, Phoenix
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 2 sep. 2026 · NCT07610473

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

  • IMA Clinical Research Phoenix, Phoenix
RekryterarFas 3
Ålder 18 till 74 · Alla kön · Uppdaterad 3 aug. 2026 · NCT06775379

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

  • NoesisPharma, LLC, Phoenix
  • Del Sol Research Management, Tucson
RekryterarFas 2
Ålder 18 till 64 · Alla kön · Uppdaterad 27 juli 2026 · NCT07115329

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

  • Clinical Research Site, Tucson
RekryterarFas 3
Ålder 18 till 65 · Alla kön · Uppdaterad 24 juli 2026 · NCT07484217

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

  • Ima Clinical Research Phoenix (Alea) /ID# 277516, Phoenix
RekryterarFas 2
Ålder 18 till 65 · Alla kön · Uppdaterad 15 juni 2026 · NCT07276997

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

  • Noble Clinical Research, Tucson
RekryterarFas 2
Ålder 18 till 65 · Alla kön · Uppdaterad 11 maj 2026 · NCT06524830

Study of ALTO-300 in MDD

  • Site 200, Phoenix
  • Site 187, Yuma
RekryterarFas 2
Ålder 18 till 70 · Alla kön · Uppdaterad 24 juli 2025 · NCT05922878

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.